Amneal Pharmaceuticals (AMRX) EBT Margin (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly EBT Margin of 11.1% for Q1 2026, up 571.0% year-over-year from 1.65% in Q1 2025, and up 63.6% quarter-over-quarter from 6.78% in Q4 2025.
Amneal Pharmaceuticals (AMRX) EBT Margin (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' EBT Margin history runs 10 years deep, the most recent figure standing at 11.1% for Q1 2026.
- In Q1 2026, EBT Margin rose 571.0% year-over-year to 11.1%; the TTM figure through Mar 2026 stood at 5.97% (up 392.0% YoY), while the FY2025 annual figure was 4.61%, up 658.0% from the prior year.
- EBT Margin for Q1 2026 stood at 11.1%, up from 6.78% in the prior quarter.
- The five-year high for EBT Margin was 11.1% in Q1 2026, with the low at 41.61% in Q2 2022.
- The 5-year median for EBT Margin is 0.48% (2022), against an average of 1.65%.
- The sharpest annual moves came in 2022 and 2023: EBT Margin plunged 4812 bps in 2022, then surged 4656 bps in 2023.
- Amneal Pharmaceuticals' EBT Margin stood at 0.48% in 2022, then sank by 2897 bps to 13.53% in 2023, then soared by 84 bps to 2.1% in 2024, then jumped by 423 bps to 6.78% in 2025, then surged by 64 bps to 11.1% in 2026.
- Business Quant data shows AMRX's EBT Margin at 11.1% in Q1 2026, 6.78% in Q4 2025, and 0.67% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 8.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.92% |
| Mar 31, 2026 | 11.10% |
| Dec 31, 2025 | 6.78% |
| Sep 30, 2025 | -0.67% |
| Jun 30, 2025 | 7.14% |
| Mar 31, 2025 | 5.39% |
| Dec 31, 2024 | -2.10% |
| Sep 30, 2024 | 2.20% |
| Jun 30, 2024 | 2.91% |
| Mar 31, 2024 | -11.46% |
| Dec 31, 2023 | -13.53% |
| Sep 30, 2023 | 3.70% |
| Jun 30, 2023 | 4.95% |
| Mar 31, 2023 | -1.69% |
| Dec 31, 2022 | 0.48% |
| Sep 30, 2022 | 0.40% |
| Jun 30, 2022 | -41.61% |
| Mar 31, 2022 | -1.99% |
| Dec 31, 2021 | -3.04% |
| Sep 30, 2021 | -0.39% |